J. Michael Dixon, MD, professor of Surgery, consultant surgeon, and clinical director of the Breakthrough Breast Cancer Research Unit at the University of Edinburgh in Scotland, discusses the prevalence of and risk factors for breast cancer in males.
J. Michael Dixon, MBChB, MD, discusses the need for physicians to inform patients of the pros and cons before having a mastectomy.
J. Michael Dixon, MBChB, MD, Professor of Surgery, Consultant Surgeon, University of Edinburgh, Clinical Director of the Edinburgh Breast Unit, Western General Hospital, Edinburgh, Scotland, discusses the discrepancy in the rate of mastectomies.
Dr. J. Michael Dixon, from Western General Hospital, Scotland, Advises Against Mastectomies
Dr. J. Michael Dixon, from the University of Edinburgh, Discusses Making the Decision to have a Mastectomy
Dr. Michael Dixon from University of Edinburgh on Systems Biology Determining Therapy Combinations
Dr. J. Michael Dixon from University of Edinburgh on Letrozole Used in Combination With Pathway Inhibitors
Dr. J. Michael Dixon from University of Edinburgh on Advances in Breast Cancer Systemic Therapy
Dr. J. Michael Dixon from the University of Edinburgh on Advances in Breast Cancer Axillary Node Procedures
Dr. J. Michael Dixon from the University of Edinburgh Discusses Advances in Breast Cancer Treatment
August 10th 2016
September 6th 2011
September 28th 2011
September 15th 2011
April 2nd 2012
April 26th 2012
